Goldman S, Levivier M, Pirotte B, Brucher J M, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J
PET/Biomedical Cyclotron Unit, Service de Neurologie, ULB-Hôpital Erasme, Brussels, Belgium.
J Nucl Med. 1997 Sep;38(9):1459-62.
Gliomas are regionally heterogeneous tumors. The local relationship between histologic features and radiotracer uptake evaluated by PET should therefore influence analysis and interpretation of PET results on gliomas. This study explored this local relationship as a result of PET guidance of stereotactic biopsies.
Local histology was confronted to the regional uptake of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) and 11C-methionine (11C-MET) in 14 patients with high-grade glioma diagnosed during a procedure of PET-guided stereotactic biopsies. We analyzed the uptake of both tracers in regions of interest centered on the stereotactic coordinates of 93 biopsy samples.
A semiquantitative analysis revealed a significant regional correlation between 11C-MET and 18F-FDG uptakes. Uptake of both tracers was significantly higher on the site of tumor samples showing anaplastic changes than in the rest of the tumor. Presence of necrosis in anaplastic areas of the tumor significantly reduced the uptake of 11C-MET.
PET with 11C-MET and 18F-FDG may help to evaluate, in vivo, the metabolic heterogeneity of human gliomas. Anaplasia is a factor of increased uptake of both tracers, but microscopic necrosis in anaplastic areas influences their uptake differently. This finding probably relates to the differences in tracer uptake by non-neoplastic components of necrotic tumors. These results underline the complementary role of 18F-FDG and 11C-MET for the study of brain tumors and favors their use for stereotactic PET guidance of diagnostic or therapeutic procedures.
胶质瘤是具有区域异质性的肿瘤。因此,通过正电子发射断层扫描(PET)评估的组织学特征与放射性示踪剂摄取之间的局部关系应会影响对胶质瘤PET结果的分析和解读。本研究在PET引导立体定向活检的情况下探索了这种局部关系。
在PET引导立体定向活检过程中诊断为高级别胶质瘤的14例患者中,将局部组织学与18F-2-氟-2-脱氧-D-葡萄糖(18F-FDG)和11C-蛋氨酸(11C-MET)的区域摄取情况进行对照。我们分析了以93个活检样本的立体定向坐标为中心的感兴趣区域中两种示踪剂的摄取情况。
半定量分析显示11C-MET与18F-FDG摄取之间存在显著的区域相关性。在显示间变改变的肿瘤样本部位,两种示踪剂的摄取均显著高于肿瘤的其他部位。肿瘤间变区域出现坏死会显著降低11C-MET的摄取。
11C-MET和18F-FDG PET可能有助于在体内评估人类胶质瘤的代谢异质性。间变是两种示踪剂摄取增加的一个因素,但间变区域的微小坏死对它们摄取的影响不同。这一发现可能与坏死肿瘤的非肿瘤成分对示踪剂摄取的差异有关。这些结果强调了18F-FDG和11C-MET在脑肿瘤研究中的互补作用,并支持它们用于诊断或治疗程序的立体定向PET引导。